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Abstract
We aimed to understand the genetic control of cardiac remodeling using an isoproterenol-
induced heart failure model in mice, which allowed control of confounding factors in an experi-
mental setting. We characterized the changes in cardiac structure and function in response to
chronic isoproterenol infusion using echocardiography in a panel of 104 inbredmouse strains.
We showed that cardiac structure and function, whether under normal or stress conditions,
has a strong genetic component, with heritability estimates of left ventricular mass between
61% and 81%. Association analyses of cardiac remodeling traits, corrected for population
structure, body size and heart rate, revealed 17 genome-wide significant loci, including sev-
eral loci containing previously implicated genes. Cardiac tissue gene expression profiling,
expression quantitative trait loci, expression-phenotype correlation, and coding sequence
variation analyses were performed to prioritize candidate genes and to generate hypotheses
for downstreammechanistic studies. Using this approach, we have validated a novel gene,
Myh14, as a negative regulator of ISO-induced left ventricular mass hypertrophy in an in vivo
mouse model and demonstrated the up-regulation of immediate early geneMyc, fetal gene
Nppb, and fibrosis gene Lgals3 in ISO-treatedMyh14 deficient hearts compared to controls.
Author Summary
Heart failure is the most common cause of morbidity and mortality in the aging popula-
tion. Previous large-scale human genome-wide association studies have yielded only a
PLOSGenetics | DOI:10.1371/journal.pgen.1006038 July 6, 2016 1 / 30
a11111
OPEN ACCESS
Citation:Wang JJ-C, Rau C, Avetisyan R, Ren S,
Romay MC, Stolin G, et al. (2016) Genetic Dissection
of Cardiac Remodeling in an Isoproterenol-Induced
Heart Failure Mouse Model. PLoS Genet 12(7):
e1006038. doi:10.1371/journal.pgen.1006038
Editor: Tim Wiltshire, University of North Carolina,
UNITED STATES
Received: December 18, 2015
Accepted: April 18, 2016
Published: July 6, 2016
Copyright: © 2016 Wang et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper, its Supporting Information files, and
the Gene Expression Omnibus 19 (GEO) online
database http://www.ncbi.nlm.nih.gov/geo/
(Accession GSE48760).
Funding: This work was supported by the National
Institute of Health National Heart, Lung, and Blood
Institute: National Institute of Health National Heart,
Lung, and Blood Institute: T32 HL007895 (JJW),
T32HL69766 (CR), R21 HL110667 (AJL), R01
HL114437 (AJL), R01 HL123295 (YW); National
Institute of General Medical Sciences: GM114833
(JJW) The funders had no role in study design, data
handful of genetic loci contributing to heart failure-related traits. Using a panel of diverse
inbred mouse strains, treated with a β-adrenergic agonist isoproterenol to mimic the heart
failure state, we sought to uncover the contribution of common genetic variation in heart
failure. We found that heart failure has a strong genetic component. We successfully iden-
tified 17 genome-wide significant loci associated with indices of heart failure. We showed
that genetic variation in a novel geneMyh14 affects heart failure by altering the mechanical
responses of heart muscles to isoproterenol-induced stress. Follow-up studies of this gene
and additional candidate genes and loci should reveal potential mechanisms by which
genetic variations contribute to heart failure in the general human population. Such
insights may lead to improved diagnosis and tailor treatment based on the genetic makeup
of individuals in the population.
Introduction
Heart failure (HF) is a major health issue, affecting 5.7 million people in the United States [1].
Despite advances in therapy, HF remains a lethal condition with 5- and 10-year mortality rates
of greater than 40% and 60% [2]. A number of etiologic factors, such as coronary artery disease,
hypertension, valvular disease, alcohol, chemotherapy, and rare deleterious genetic mutations
can lead to cardiac injury that results in HF but little is known about how common genetic var-
iants contribute to HF progression. Irrespective of the primary insult, compensatory adrenergic
and renin-angiotensin activation augment heart rate (HR), contractility and fluid retention to
maintain adequate cardiac output and preserve organ function, which in turn leads to chronic
maladaptive cellular growth and irreversible myocardial injury, furthering HF progression [3].
Such molecular, cellular and extracellular changes, manifested clinically as changes in size,
shape and function of the heart, is also known as cardiac remodeling and is one of the most
important clinical determinants of HF progression. In addition, β-adrenergic receptor blockers
and angiotensin-converting enzyme (ACE) inhibitors, HF therapeutic agents that provide mor-
bidity and mortality benefits, reverse ventricular dilation and systolic dysfunction, further sup-
porting the importance of clinical cardiac remodeling as HF therapeutic targets [4,5].
Understanding how common genetic variation modifies the pathophysiology of HF progres-
sion in terms of cardiac remodeling will likely provide insights in the design of novel therapeu-
tics to improve survival and life quality of HF patients.
The unbiased genome-wide association study (GWAS) design is well suited to detect the
effects of genetic variation on complex traits such as HF [6]. However, a number of human HF
GWAS performed to-date have had limited success. For example, a study on cardiac structure
and function yielded one significant locus explaining<1% of variance in left ventricular dia-
stolic diameter (LVIDd) [7]. A meta-analysis of 4 community-based GWAS cohorts, involving
nearly 24,000 subjects, identified only two loci to be significantly associated with incident HF,
explaining a very small fraction of the variance [8]. A sporadic dilated cardiomyopathy GWAS,
involving 1179 cases and 1108 controls from several European populations, identified only two
associated loci [9]. Lastly, a GWAS of cardiac structure and function in 6,765 African Ameri-
cans identified 4 loci associated with left ventricular mass (LVM), interventricular septal wall
thickness (IVSd), LVIDd, and ejection fraction (EF) [10]. In spite of their scales, the paucity of
detailed phenotypic data as well as environmental heterogeneity hampered detection of genetic
signals driving HF in these large human cohorts.
The laboratory mouse, with its fully sequenced and annotated genome, targeted germ line
modification and easy accessibility, provides a means of overcoming some of the challenges in
AGenome-Wide Association Study of Heart Failure in Mice
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human studies and is complementary. Particularly informative have been reverse genetic stud-
ies of candidate genes and pathways utilizing engineered mouse models. Studies of natural vari-
ation of mice and rats, some involving sensitized models, have also resulted in the
identification of novel pathways contributing to HF and other common cardiovascular traits
[11,12,13,14,15]. A major difficulty of the latter, however, has been the poor resolution of clas-
sical linkage studies, making the identification of underlying causal genes a laborious process.
Recently, with the development of high-density genotyping and sequencing in rodents, rela-
tively high-resolution association mapping approaches, analogous to human GWAS, have
become feasible [16]. Our group has pioneered a resource termed the Hybrid Mouse Diversity
Panel (HMDP), a panel of 100+ strains of inbred mice that have either been sequenced or
densely genotyped and display natural inter-strain genetic variation, allowing a mapping reso-
lution more than an order of magnitude higher than traditional crosses [17]. The method com-
bines the use of classic inbred strains for mapping resolution and recombinant inbred (RI)
strains for power and has been used to successfully identify a number of genes and loci
involved in lipid, obesity, bone, and behavioral traits [16,18,19,20]. Because the HMDP strains
are renewable, the resource is well suited to the application of systems genetics approaches,
involving the integration of high throughput molecular phenotypes, such as expression array
data, with clinical phenotypes.
We have previously reported a genetic analysis of β-adrenergic agonist isoproterenol (ISO)-
induced cardiac hypertrophy in the HMDP, identifying a number of loci contributing to heart
weight and fibrosis [21]. We now extend this study to examine ISO-induced cardiac remodel-
ing, i.e. cardiac structural and functional changes as characterized by serial echocardiography,
a powerful and noninvasive tool to serially monitor cardiac structure and function in murine
injury models [22,23]. We demonstrate fine phenotypic data across the concentric-eccentric
and functional cardiac remodeling spectra and found that cardiac remodeling traits among the
HMDP are highly heritable. Using a common genetic variation association method, we identify
17 genome-wide significant loci with high resolution that modify ISO-induced cardiac remod-
eling in the heart, many of which are less than 1 Mb in size. Then, we utilize expression arrays
from left ventricular (LV) tissues, with and without ISO treatment, to understand the genetic
control of gene expression and gene expression correlation to cardiac remodeling phenotypes
to further prioritize candidate genes in each locus. Finally, using in vitro and in vivomodels, we
validate a novel geneMyh14 as causative in ISO-induced cardiac remodeling not previously
reported in our heart weight analyses [21].
Materials and Methods
Ethics statement
All animal experiments were conducted following guidelines established and approved by the
University of California, Los Angeles Institutional Animal Care and Use Committee. Induction
and maintenance dosages of isoflurane was used to ensure adequate sedation while minimizing
the effects of inhaled isoflurane on loading conditions, heart rate, cardiac structure and func-
tion during echocardiogram. At the end of the protocol, mice were sacrificed by sub-lethal dos-
age of isoflurane anesthesia followed by cervical dislocation.
Chronic β-adrenergic stimulation, echocardiography, and tissue
collection from the HMDP
HMDPmice. Breeding pairs from the HMDP inbred strains were obtained from the Jack-
son Laboratory (Bar Harbor, ME, USA). Eight- to ten-week-old nulliparous female offspring
AGenome-Wide Association Study of Heart Failure in Mice
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from the following 104 mouse strains were used, including 30 classical inbred strains (129X1/
SvJ, A/J, AKR/J, BALB/cByJ, BALB/cJ, BTBRT<+>tf/J, BUB/BnJ, C3H/HeJ, C57BL/6J,
C57BLKS/J, C57L/J, C58/J, CBA/J, CE/J, DBA/2J, FVB/NJ, KK/HlJ, LG/J, LP/J, MA/MyJ,
NOD/LtJ, NON/LtJ, NZB/BlNJ, NZW/LacJ, PL/J, RIIIS/J, SEA/GnJ, SJL/J, SM/J, SWR/J) and
74 recombinant inbred (RI) strains [RI (number of strains)–AXB (8), BXA (10), BXD (44),
BXH(5), CXB (7)]. All animal experiments were conducted following guidelines established
and approved by the University of California, Los Angeles Institutional Animal Care and Use
Committee.
Chronic β-adrenergic stimulation and tissue collection. Using i.p. ketamine as a surgical
anesthetic agent, ALZET Model 1004 minipumps (Cupertino, CA, USA) were implanted intra-
peritoneally to administered ISO, a non-selective β-adrenergic agonist that has been used
widely to mimic the HF state in experimental animals [24,25], at a dose of 30 mg/kg body
weight/day for 21 days. Approximately four ISO-treated (S5 Table) and 2–4 control ([21] S1
Table) mice from each strain were examined. At the end of the protocol, mice were sacrificed
by giving a sub-lethal dosage of inhaled isoflurane followed by cervical dislocation. LV tissues
were collected and frozen immediately in liquid nitrogen.
Echocardiography. To ensure adequate sedation while minimizing the effects of inhaled
isoflurane on loading conditions, HR, cardiac structure and function, we minimized induction
and maintenance doses of isoflurane at or below 1.25% and 1%, respectively, while closely
monitoring for HR< 475 bpm as a sign for deep sedation and adjusting isoflurane dosage as
needed [26].
A single operator (JJW), who followed a standard operating protocol detailed below, per-
formed all of the echocardiograms using the Vevo 770 ultrasound system (VisualSonics, Inc.,
Toronto, ON, Canada): A parasternal long-axis B-mode image was obtained. The maximal
long-axis of the LV was positioned perpendicular to the ultrasound beam. A 90° rotation of the
ultrasound probe at the papillary muscle level was performed to obtain a parasternal short-axis
view of the LV. A M-mode image to document LV dimensions was captured and saved for
analysis. At a later time, saved images were analyzed using the Vevo 770 cardiac analysis pack-
age by a single observer (JJW) who was blinded to mouse strains.
A baseline echocardiogram was performed on all the mice. In ISO-treated mice, serial echo-
cardiograms were performed at 1, 2, and 3 weeks of treatment. In control mice, a second echo-
cardiogram was performed in 70 mouse strains at week 3 as an internal control. The
reproducibility of our echocardiographic measurements was assessed using the Bland-Altman
plots, which demonstrated acceptable agreement between week 0 and week 3 control measure-
ments (S1B Fig). IVSd and LVM were not statistically different between the 2 time points,
although fractional shortening (FS) was 2.3% higher and LVIDd 0.07 mm lower at week 3 com-
pared to baseline (p = 0.002 and 0.019, respectively), possibly due to the effects of co-housing
with ISO-treated animals (S1 Table).
Transcriptome profiling and analysis
RNA extraction. Frozen LV tissues were homogenized in QIAzol Lysis Reagent prior to
RNA isolation using RNeasy columns (QIAGEN, Valencia, CA, USA). RNA quality was
assessed using the Bioanalyzer RNA kits (Agilent Technologies, Santa Clara, CA, USA).
RIN 7.0 was considered acceptable.
Expression array profiling. Expression profiling of pooled biological replicates was per-
formed using Illumina MouseRef-8 v2.0 Expression BeadChip arrays (Illumina, Inc., San
Diego, CA, USA). To minimize artifacts due to single nucleotide polymorphisms (SNPs), we
excluded probes that aligned to sequences containing known SNPs. Background correction
AGenome-Wide Association Study of Heart Failure in Mice
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and quantile normalization of the image data was performed using the neqc method from the
R package limma [27]. Hierarchical clustering of samples was performed to exclude outlier
samples using the R package WGCNA [28]. In total, expression profiles for 90 control and 91
ISO strains (including 82 strains with matching control and isoproterenol samples) were
included in downstream analyses.
Differential gene expression. Using the R package limma, moderated t-statistics and the
associated p values were calculated. Multiple testing was corrected by controlling for false dis-
covery rate using the Benjamini-Hochberg procedure [29]. Probes with log2-fold change> 0.2
and adjusted p-value< 0.05 were considered significantly differentially expressed. Functional
analysis of probe lists was performed using the Database for Annotation, Visualization and
Integrated Discovery (DAVID) [30] to identify pathways and cellular processes enriched in
genes differentially regulated by ISO stimulation [30,31]. In total 1,502 of the 18,335 probes
(8.2%) were differentially expressed at> 15% change at an adjusted p-value< 0.05, including
840 up-regulated and 662 down-regulated probes (S2A Table). DAVID gene ontology analysis
was performed on the differentially expressed probes as well as the top 1000 correlated tran-
scripts for each phenotype-expression pair (S2B–S2D Table).
Statistical analyses, heritability estimation, association mapping and
candidate prioritization
Statistical analysis and graphical display. The standard R program was used to per-
formed t-test. The R package vioplot was used to plot violin plots. The R package corrplot was
used to plot correlations among traits. Consistent with time series data, serial measurements of
the same trait were generally correlated to each other with adjacent time points being the most
correlated. Of note, LVM was a calculated measure based in part on IVSd and LVIDd; there-
fore, it is not surprising that LVM was correlated with IVSd and LVIDd at each time point.
The R package FactoMineR was used to compute principal component analysis and display
variables factor map and individuals factor map. The R package WGCNA was used to calculate
biweight midcorrelation (bicor), which is a median based correlation measure that is more
robust than the Pearson correlation but often more powerful than the Spearman correlation.
The proportion of variance (ω2) explained was computed from the formula:
o2 ¼ SSQcondition  ðk 1ÞMSE
SSQtotal þMSE
ð1Þ
where MSE is the mean square error and k is the number of conditions.
Genotypes. The HMDP mouse strains were previously genotyped using the JAX Mouse
Diveristy Genotyping Array [32,33]. To select for informative and high quality SNPs, each
SNP was filtered for> 5% minor allele frequency and< 10% missing values among the strains
using plink [34]. Approximately 210,000 of the informative SNPs were selected.
Heritability calculation. Heritability is the proportion of observed differences due to
genetic variation in the population. Specifically, broad-sense heritability (H2) reflects all the
genetic contributions to a population's phenotypic variance including additive, dominant, and
epistatic effects, while narrow-sense heritability (h2) represents the proportion of phenotypic
variance that is due to additive genetic effects alone. In inbred model organisms, repeatability
expresses the proportion of variation in a trait that is due to differences between individual
strains and not due to differences within individual strains. Under the assumption that all dif-
ferences between genotypes are genetic and not due to genotype-environment correlation,
repeatability is equal to broad-sense heritability; otherwise it only provides an upper-bound for
broad-sense heritability. Using the R package heritability [35], an analysis of variance
AGenome-Wide Association Study of Heart Failure in Mice
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(ANOVA)–based method that accounts for differing numbers of replicates, called line repeat-
ability, was used to estimate H2 for each phenotype and time point. In addition, a linear model
method incorporating genetic relatedness matrix and within-strain variability, called marker-
based h2, was used to compute h2 and confidence intervals.
Genome-wide significance threshold. The threshold for genome-wide significance was
determined by simulation and permutation of strain genotypes, as previously described [19].
The significance threshold for clinical traits was determined to be 4.1 x 10−6. The significance
threshold for cis-eQTL and trans-eQTL were 3.63 x 10−3 and 6.1 x 10−5, respectively. Given
that the studied traits could be collapsed to roughly a handful of PCs, the significance threshold
for clinical trait analyses was kept at the nominal p-value of 4.1 x 10−6, without Bonferroni
adjustment for multiple testing.
Association mapping. We used the Factored Spectrally Transformed Linear Mixed Mod-
els (FaST-LMM) to test for association while accounting for population structure and genetic
relatedness among strains as previously described [36], which produced the same results as effi-
cient mixed-model association (EMMA) but with a run time and memory footprint that is
only linear to the cohort size (S2 Fig). Association mapping was performed for echocardio-
graphic measurements at each time point and the change in measurements from baseline at
each time point while adjusting for baseline body weight (BBW) and HR to define clinical
quantitative trait loci (cQTL). In addition, association mapping for gene expression traits,
under baseline and isoproterenol-treated conditions, was performed to define expression quan-
titative trait loci (eQTL). As a general rule, upwards of 90 to 100 strains are required to ensure
stable mapping results.
Linkage disequilibrium block boundaries. Linkage disequilibrium (LD) is the non-ran-
dom association of alleles generally near one another at a locus. SNPs in strong LD tend to
have association p-values that are similar in strength. Genomic boundaries around lead associ-
ation SNPs were chosen based on flanking SNPs with p-values< 1 x 10−5 that were no more
than 2 Mb apart between nearest consecutive pairs. Lead SNPs without any neighboring SNPs
at p-value< 1 x 10−5 were excluded. LD between lead SNPs and flanking SNPs were calculated
and visualized by plotting regional plots using a custom-built of LocusZoom [37] based on our
HMDP mice.
Candidate gene prioritization. Genes within LD (r2> 0.8) of the lead SNPs were exam-
ined for coding sequence and splice region variations using the Wellcome Trust Mouse
Genomes Project (MGP) sequencing database [38] using a vcftools-based pipeline. SIFT score,
a functional annotation score for non-synonymous variants, was noted whenever available
[39]. The expression profiles of genes within LD or nearby the lead SNPs were further exam-
ined for the presence of cis-expression quantitative trait loci (cis-eQTL). When a transcript’s
cis-eQTL coincides with the clinical trait locus and is correlated with the trait, a causal relation-
ship between the locus, the transcript and the trait may be inferred.
Myh14 functional validation in NRVM and in knock-out mice
siRNA knock-down neonatal rat ventricular myocytes. Neonatal rat ventricular myo-
cytes (NRVMs) were isolated and cultured at the UCLA NRVM core facility using 2–4 day old
rats. Myocytes and fibroblasts were separated using Percoll density gradient. NRVMs were
plated at 375,000 cells/well in DMEM + 10% FBS + 100 U/mL penicillin + 100 μg/mL strepto-
mycin (p/s) on Day 1. On the morning of Day 2, plated NRVMs were transfected with 30 pmol
per well of siRNA (siMyh14#1—#RNC.RNAI.N001100690.12.1, siMyh14#2—RNC.RNAI.
N001100690.12.6., or scrambled control purchased from IDT) using Lipofectamine 2000 (Life
Technologies) and media changed to DMEM + 1% ITS (Insulin, Transferrium and Selenium)
AGenome-Wide Association Study of Heart Failure in Mice
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without p/s forMyh14 knockdown experiments. On Day 3, at 24 hours following transfection,
cells were treated with 20 μM ISO or 50 μM phenylephrine (PE) for an additional 24 hours
prior to bright field imaging on day 4.
MTT Assay was performed using the Vybrant MTT Cell Proliferation Assay Kit (Life Tech-
nologies V13154). Briefly, NRVMs were plated in 96 well plates at a density of 10,000 cells per
well and were transfected with either scrambled control orMyh14 siRNA using Lipofectamine
RNAimax overnight. Cells were then treated the next day with 20 μM ISO or 50 μM PE for 24
hours and then viability was assayed using MTT.
Myh14 knock-out mice. Myh14-/- mice generated on a 129/Sv background followed by
backcrossing to strain C57BL/6 for more than 7 generations were obtained from the Adelstein
lab [40] and backcrossed (Myh14-/- male x C57BL/6J female) to generateMyh14+/- mice.
Myh14+/- heterozygous crosses generated wild-type (WT), heterozygous (HET) and homozy-
gous (KO) littermates at normal mendelian ratios (Chi-Square test p = 0.13, S3 Table). Six WT,
nine HET, and seven KO twelve-week-old nulliparous female mice were subjected to chronic
β-adrenergic stimulation and echocardiogram in the same manner as in the HMDP described
above.
Histology and immunofluorescence microscopy. Hearts were fixed in 10% paraformal-
dehyde in PBS. Masson’s trichrome staining and immunofluorescence staining were performed
as previously described [40]. The antibodies used for immunofluorescence staining were N-
cadherin (mouse, 1:2000, Invitrogen), β-catenin (mouse, 1:1000, Zymed), and wheat germ
agglutinin (WGA). Paraffin embedded heart sections were first dewaxed and rehydrated by
standard procedures. Following antigen retrieval in citric acid buffer (10 mM, pH 6.0), the sec-
tions were blocked with 1% BSA/5% goat serum in PBS for 1 hour at room temperature and
then incubated with Alexa Fluor 594-WGA (10 μg/ml, Invitrogen) and DAPI in blocking solu-
tion for 1 hour at room temperature. The slides were then washed and mounted using Prolong
Anti-fade mount media (Invitrogen).
Accession numbers
Expression array data are deposited in the Gene Expression Omnibus 19 (GEO) online data-
base http://www.ncbi.nlm.nih.gov/geo/ (Accession GSE48760).
Results
Experimental design and quality control
We characterized 104 classical and RI mouse strains by obtaining echocardiographic measure-
ments under the baseline condition and in response to chronic ISO administration for 3 weeks
(Fig 1). Global gene expression profiling of LV tissues from control and ISO-treated mice was
performed to identify genes whose expression was correlated to HF traits and to identify
eQTLs to prioritize candidate genes. We previously reported association mapping of heart
weight and fibrosis [21]; the present study focuses on echocardiographic measures of clinical
significance, including IVSd, LVIDd, LVM and FS, to enable mapping of fine cardiac remodel-
ing phenotypes due to ISO-treatment.
To minimize inter-operator and inter-observer variation, all echocardiograms were per-
formed by a single operator and interpreted by the same observer who was blinded to strain
name and treatment assignment. Inhaled isoflurane was titrated to achieve adequate sedation,
while maintaining target HR above 475 bpm. The Bland-Altman plot, which shows the agree-
ment between two quantitative methods, demonstrated acceptable differences between ISO-
treated LVM (a calculated value based on echo parameters) and LV weight (a weighed value
after LV was dissected from the atria and RV) estimates (S3A–S3C Fig). LVM by
AGenome-Wide Association Study of Heart Failure in Mice
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echocardiogram was significantly correlated to LV weight at sacrifice (r = 0.77 in control and
r = 0.85 in ISO both with p-value < 2.2 x 10−16), validating our echocardiographic measures
externally.
The HMDP exhibits significant variation in cardiac structure and function
both under baseline and ISO-treated conditions
We observed striking variation in cardiac structure and function among the HMDP strains
both under baseline condition and in response to chronic ISO administration (Fig 2 and S4
Fig). Importantly, the phenotypic spectrum among the BXD RI lines exceeded that of their
parental strains C57BL/6 and DBA/2, consistent with cardiac remodeling being a complex trait
involving multiple genes (S5 Fig). Of note, the phenotypic spectra on ISO treatment were sig-
nificantly broader than baseline, consistent with ISO perturbation enhancing the phenotypic
variation among HMDP strains (Fig 3A and 3B). Moreover, across the HMDP strains, IVSd
and FS increased significantly at week 1 and attenuated at later time points, reflecting the acute
and chronic effects of ISO on septal wall hypertrophy and cardiac inotropy. LVIDd and LVM
progressively increased with ISO treatment at each time point, reflecting progressive changes
in LV chamber dimension and LV mass due to ISO (S4 Table). While many of the strains fol-
low the general population trend described above, strains particularly susceptible to adverse
cardiac remodeling, such as KK/HlJ and BTBRT<+>tf/J, demonstrated significantly decreased
FS and increased in LVIDd (Fig 3C). The observed phenotypic variation, especially upon ISO
treatment, underpins the basis for association mapping. The strain-level phenotype data are
provided in S5 Table for reference.
The HMDP demonstrates the presence of a compensatory-
decompensating phenotypic spectrum
We performed correlation analysis across the HMDP to further understand the phenotype
data observed. Not surprisingly, baseline body weight (BBW), a surrogate for body size, was
significantly correlated with LVM and LVIDd but not with FS (S6A Fig), consistent with larger
mice having larger and heavier hearts but body size not being a determinant of systolic heart
function. In addition, under the baseline and ISO-treated conditions, HR was positively corre-
lated with FS and negatively correlated with LVIDd. This observation is consistent with known
Fig 1. Experimental design.We characterized 104 classical and recombinant inbred mouse strains of the
Hybrid Mouse Diversity Panel (HMDP) by serial echocardiograms at baseline, week 1, week 2, and week 3
under the control condition or chronic isoproterenol (ISO) infusion. The✪ symbol indicates the time points
echocardiograms were performed.
doi:10.1371/journal.pgen.1006038.g001
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negative chronotropic and inotropic effects of isoflurane on the heart and reflects the varying
degrees of isoflurane sensitivity among HMDP strain. In fact, HR was significantly correlated
across control and different ISO-treated time points, indicative of a strain-specific HR response
to ISO. (S6B and S6C Fig). Interestingly, HR had no significant correlation with LVM esti-
mates. Based on these findings, we chose to correct for confounding effects of body size and
isoflurane sensitivity using BBW and HR as surrogate markers in downstream analyses.
BBW- and HR-adjusted partial correlations among pairs of echocardiographic and LV
weight traits showed that ISO treatment uncoupled many measures of cardiac structure and
function from baseline (Fig 4A). ISO-treatment introduced an immediate perturbation on FS,
such that FS from week 1 onwards was uncorrelated to FS at baseline, possibly due to different
genetic factors controlling FS before and after ISO. In fact, FS at week 1 was negatively corre-
lated with LVIDd at later time points, consistent with week 1 FS being a measure of contractile
reserve and an early predictor of progressive ventricular dilation. In contrast, ISO-induced per-
turbation on IVSd was not observed until week 2. IVSd hypertrophy was positively correlated
with increased FS and negatively correlated with LVIDd dilation, consistent with the presence
of a compensatory-decompensating spectrum that is genetically controlled and required for
association mapping (Fig 4B).
To describe each strain based on a composite of correlated traits, we used principal compo-
nent (PC) analysis to transform ISO-induced changes into a set of linearly uncorrelated vari-
ables. The first three PCs account for 35%, 28% and 11% of the inter-strain variance observed,
with the remaining PCs each accounting for< 10% of the variance observed. The variables
Fig 2. Variation in echocardiographic measures of cardiac structure and function among HMDPmouse strains. Black bars represent
measurements under the baseline condition in ranked order. White bars represent measurements after 3 weeks of continuous ISO infusion.
IVSd = interventricular septal wall thickness; LVIDd = left ventricular diastolic diameter; LVM = left ventricular mass; FS = fractional shortening. Error bars
represent the standard errors of the means.
doi:10.1371/journal.pgen.1006038.g002
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factor map showed that the first three PCs captured phenotypes such as LVIDd dilation and FS
decrease; LVM hypertrophy; and early IVSd increase (Fig 5A). The individuals factor maps
highlighted KK/HlJ with decompensating features, such as LVIDd dilation and FS decrease,
and NZW/LacJ with compensatory features, such as late IVSd and LVM increase and preserved
FS (Fig 5B and 5C).
Fig 3. Population distribution of echocardiographic measures at each time point. The violin plot is a combination of a boxplot and a kernel density
plot (a smooth histogram) rotated on its side. The white dot represents the median. The black box represents the interquartile range (IQR). The black
vertical line represents the whiskers spanning the lowest and the highest data within 1.5 IQR from the lower and upper quartile. A) The population
distribution at each ISO treatment time point. B) The distribution of the changes in echocardiographic measures from baseline. C) The changes in
echocardiographic measures compared to baseline at each ISO time point for individual classical inbred strains.
doi:10.1371/journal.pgen.1006038.g003
AGenome-Wide Association Study of Heart Failure in Mice
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Additive effects account for roughly half of the heritability estimates of
cardiac structure and function across the HMDP
Heritability is the proportion of observed differences due to genetic variation in the popula-
tion. Specifically, broad-sense heritability (H2) reflects all the genetic contributions to a popu-
lation's phenotypic variance including additive, dominant, and epistatic effects, while narrow-
sense heritability (h2) represents the proportion of phenotypic variance that is due to additive
genetic effects alone. In inbred model organisms, where the environment is controlled and
multiple animals of identical genetic background are available, between-strain and within-
strain variation can be used to estimate H2, which reflects all genetic contribution to pheno-
typic variance. The majority of the traits we examined were highly heritable (H2 > 0.4) (S7
Fig). H2 estimates of LVM in the HMDP were between 61 and 81% (Table 1), which is similar
to estimates for other common traits, such as body fat and insulin resistance, in the HMDP
panel [18] and consistent with genetic factors making a significant contribution to cardiac
structure and function. Narrow-sense heritability h2, the proportion of phenotypic variance
due to additive genetic effects alone, incorporates genetic marker information and is the theo-
retical upper bound of what could be mapped in an association study. Narrow-sense heritabil-
ity estimates h2 of LVM were from 39 to 57% (Table 1). Our results suggest that additive and
non-additive effects, such as dominant and epistatic gene x gene interactions, each account
for roughly half of the broad-sense heritability estimates in cardiac structural and functional
traits in mice.
Fig 4. Correlations among echocardiographic traits across time points. A) Correlations among baseline body weight- and heart rate-adjusted traits
across time points. B) Correlations among isoproterenol-induced changes in traits from baseline across time points. Colored dots represent the pairwise
correlation r values with p-values exceeding Bonferroni corrected α significance level of 0.05. LV represents LV weight. Suffixes represent weekly
echocardiographic time points under ISO treatment (0 = baseline, 1 = week 1, 2 = week 2, 3 = week 3) or control versus ISO LV weight at week 3
(c = control, i = ISO).
doi:10.1371/journal.pgen.1006038.g004
AGenome-Wide Association Study of Heart Failure in Mice
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Fig 5. Principal component analysis of isoproterenol-induced changes from baseline. A. The variables
factor map demonstrates the first three principal components that account for 74.8% of inter-strain variations. The
first principal component corresponds roughly to LVIDd dilation and FS decrease. The second principal
component corresponds to IVSd and LVM hypertrophy. The third principal component corresponds to early IVSd
hypertrophy. The individual factor map projects the inbred mouse strains onto the first three principal components.
A Genome-Wide Association Study of Heart Failure in Mice
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ISO-induced gene expression changes across the HMDP are consistent
with molecular, cellular and extracellular changes of cardiac remodeling
Human heart failure is characterized by chronic sympathetic activation to compensate for pro-
gressive cardiac function loss. Chronically, high levels of catecholamines may lead to calcium
overload, initiating a cascade of alterations at the cellular level to result in cardiomyocyte death
and progressive deterioration in cardiac structure and function. To protect itself from harmful
effects of chronic adrenergic stimulation, a protective mechanism, called desensitization,
reduced membrane availability of the beta-adrenergic receptors, leading to diminished down-
stream signaling. ISO is a non-selective β-adrenergic agonist that, when administered chroni-
cally in mice, mimics the state of chronic sympathetic activation in human heart failure [41].
Consistent with molecular changes of cardiac remodeling in humans, ISO resulted in gene
expression changes downstream of β-adrenergic receptor signaling across the HMDP mice.
β1-adrenoceptor expression decreased by 17% (Adrb1, adjusted p-value = 2.56 x 10−5) and the
inhibitory G-protein Gi increased by 16% (Gnai2, adjusted p-value = 4.47 x 10
−7), reminiscent
of diminished β-adrenergic responsiveness secondary to chronic β-adrenergic overdrive in car-
diomyopathic hearts (S2A Table). In addition, ISO downregulatedMyh7 expression by 34%
andMyh6 expression by 15% (adjusted p-value = 6.93 x 10–7 and 6.77 x 10–4, respectively),
possibly reflecting down-regulation of cardiac structural proteins or increased fibrotic tissue.
Finally, one of the most significantly up-regulated genes Lgals3 was increased by 3.5-fold
(adjusted p-value = 1.62E-22). Lgals3, or galectin-3, is an emerging clinical marker of cardiac
fibrosis, adverse LV remodeling, and mortality in HF patients [42].
Gene ontology analysis of the up- and down-regulated probes was performed to examine
the global changes in gene expression due to ISO. The up-regulated probes were most enriched
for secreted signal glycoprotein, proteinaceous extracellular matrix (ECM), angiogenesis, poly-
saccharide binding, actin cytoskeleton, vacuole, response to wounding, chemokine signaling
pathway, and epidermal growth factor (EGF)-like calcium-binding, prenylation and growth
factor binding (S2B Table). The down-regulated probes were most enriched in mitochondrial
Black dots highlight the classical (B) and recombinant (C) inbred strains and gray dots represent the remaining
HMDP strains.
doi:10.1371/journal.pgen.1006038.g005
Table 1. Heritability estimates of cardiac structure and function under isoproterenol treatment.
r2 Control Week 1 Week 2 Week 3
Broad-sense heritability estimates
IVSd 0.61 0.59 0.49 0.43
LVIDd 0.76 0.68 0.67 0.68
LVM 0.81 0.70 0.61 0.74
FS 0.73 0.64 0.60 0.68
Narrow-sense heritability estimates
IVSd 0.20 (0.12–0.31) 0.27 (0.15–0.44) 0.21 (0.09–0.41) 0.15 (0.06–0.35)
LVIDd 0.40 (0.29–0.51) 0.41 (0.27–0.57) 0.45 (0.31–0.60) 0.49 (0.34–0.64)
LVM 0.48 (0.38–0.59) 0.44 (0.31–0.58) 0.39 (0.26–0.55) 0.57 (0.43–0.70)
FS 0.30 (0.21–0.41) 0.31 (0.18–0.47) 0.34 (0.20–0.50) 0.38 (0.24–0.55)
Broad-sense heritability estimates are based on line repeatability. Narrow-sense heritability estimates are
based on marker-based heritability estimates. Ninety-five percent confidence intervals are represented
within the parentheses.
doi:10.1371/journal.pgen.1006038.t001
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matrix, mitochondrial inner membrane, and flavoprotein (S2C Table). Gene ontology analysis
of the top 1000 correlated transcripts for each phenotype-expression pair was performed to
identify processes specific for each phenotype. Under the baseline condition, transcripts that
correlated with LVIDd were modestly enriched for actin-binding, cell junction and synapse. At
week 3 of ISO, transcripts that correlated with LVID and LVM were highly enriched for pro-
teinaceous ECM, secreted signal glycoprotein, actin cytoskeleton, collagen, ECM receptor
interaction, EGF, polysaccharide binding, and mitochondrial membrane (S2D Table). These
findings provided strong evidence that ISO induced cellular and ECM changes of cardiac
remodeling found in HF.
Association mapping of cardiac remodeling and gene expression
identified candidate genes for 17 cQTL associated with ISO-induced
cardiac remodeling traits
Association mapping at each ISO-treated time point was performed to define cQTLs for BBW-
and HR-adjusted echocardiographic changes in measures from baseline. In addition, associa-
tion mapping was performed for each gene transcripts under baseline and ISO-treated condi-
tions, to define local expression quantitative trait loci (cis-eQTL) near each cQTL. Because
genetic information flows from DNA to transcript to clinical phenotypes, a transcript with an
eQTL that coincides with cQTL of a trait of interest may be hypothesized to be causal for the
trait. Using a custom pipeline that overlays cQTL, cis-eQTL, expression-phenotype correlation,
and structural variation, candidate genes for each cQTL were prioritized. The significantly
associated loci and candidate genes for echocardiographic measures are provided in Table 2.
All significantly associated loci as well as supporting evidence described above are provided in
S6 Table. All SNPs with association p-value< 0.001 are provided in S7 Table.
A total of 17 genome-wide significant cQTL were identified, including 4 for IVSd, 5 for
LVIDd, 4 for LVM and 4 for FS, many of which were less than 1 Mb in size (Table 2). As
expected, some of the correlated measures mapped to the same loci across ISO-treated time
points or traits (S8 Fig). We compared our loci with available cardiovascular disease GWAS
loci in human (S8 Table). One of the loci for week 1 IVSd hypertrophy near Fam46a on chro-
mosome 9 has previously been shown in a multi-ethnic GWAS meta-analysis to be associated
with systolic and diastolic blood pressure (p-value = 6.2 x 10−5 and 5.5 x 10−7, respectively)
[43]. One of the loci for week 1 FS near Lrp12 and Zfpm2 on chromosome 15 has previously
been shown in a small human GWAS to be associated with sudden cardiac arrest due to ven-
tricular tachycardia and ventricular fibrillation in patients with coronary artery disease (p-
value = 1 x 10−6) [44].
Klf4 is a causal gene for ISO-induced LVM hypertrophy
A locus on chromosome 4 was significantly associated with LVM at week 3 (Fig 6A). LVM
hypertrophy at weeks 1 and 2 and LV weight hypertrophy were also associated with this locus
at lesser significance levels, while baseline LVM did not map to this locus (S8A–S8C Fig).
Mouse strains with the GG and the TT genotypes at the lead SNP rs2779449 (p-value = 9.3 x
10−7) conferred a median week 3 LVM of 117 mg and 135 mg, respectively. SNP rs27794497,
located in an intergenic region between Tmem38b and Zfp462, and surrounding SNPs in LD
(r2> 0.8) spanned a region containing 4 genes (Fig 6B). Among these genes, Klf4 alone had a
significant cis-eQTL at SNP rs27794497 (p-value = 5.9 x 10−5) and was significantly correlated
with LVM hypertrophy at week 3 (bicor = -0.3, p-value = 0.0088; S8D and S9 Figs). Our results
suggest that Klf4 is a negative modulator of ISO-induced LVM. During the course of this study,
Yoshida et al. demonstrated that, when subjected to ISO, cardiomyocyte-specific Klf4 knock-
AGenome-Wide Association Study of Heart Failure in Mice
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out mice demonstrated enhanced cardiac hypertrophy, augmented cellular enlargement, exag-
gerated expression of the transcriptional regulator myocardin and fetal cardiac genes [45].
Myh14 is a causal gene for ISO-induced LVM hypertrophy
In addition, a locus on chromosome 7 was significantly associated with LVM hypertrophy at
weeks 3 (Fig 6A). This locus was also associated with LVM hypertrophy at week 1 and LV
weight hypertrophy at lesser significance levels, while baseline LVM did not map to this locus
(Fig 7). Mouse strains with the AA and the GG genotypes at the lead SNP rs40560913 (p-
value = 1.44 x 10−9) conferred a median LVM increase of 43 mg and 28 mg, respectively. SNP
rs40560913, located in the intron of Izumo2, and surrounding SNPs in LD (r2> 0.8) spanned
only one other geneMyh14 (Fig 6C).
Neither Izumo2, a sperm-specific gene, norMyh14 was represented on the expression array
used in our study. By qPCR of available matching control and ISO RNA samples in 26 mouse
strains, we foundMyh14 expression to be increased by 46% with ISO treatment (p-
value = 0.002). The available qPCR results was not adequate to map for eQTL. AsMyh14 was
represented on microarray platforms used in prior HMDP studies, we queried our cis-eQTL
database and found thatMyh14 has cis-eQTL signals across multiple tissues at the same locus
Fig 6. Genome-wide association for week 3 LVM. A. Manhattan plot for week 3 LVM. B. Regional plot for week 3 LVM around peak SNP rs27794497
(purple). C. Regional plot for week 3 LVM hypertrophy around SNP rs40560913 (purple). Pairwise r2 between the peak SNP and the surrounding SNPs
are denoted by color scale.
doi:10.1371/journal.pgen.1006038.g006
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and its expression in adipose and liver was negatively correlated with body mass normalized
heart weight at week 8 in the HMDP obesity study (S9 and S10 Tables) [18]. Based on these
findings, we hypothesized thatMyh14 was the causal gene for this locus.
MYH14 is a non-muscle myosin involved in mechanotransduction—knockout of the gene/
protein has no basal phenotype [2] and the role of MYH14 has never been comprehensively
determined in the heart. To validateMyh14 as a causal gene for LVM hypertrophy, we per-
formed siRNA knock-down ofMyh14 in neonatal rat ventricular myocytes (NRVM) followed
by phenylephrine and ISO stimulation in vitro.Myh14 knock-down demonstrated> 70% effi-
ciency (Fig 8A).Myh14 siRNA treated cells displayed poor attachment to the tissue culture
plates (Fig 8B). In addition, quantitative measurements of cell size showed thatMyh14 siRNA
treated NRVMs failed to undergo characteristic cellular hypertrophy under phenylephrine
(PE) and ISO stimulation (Fig 8C) and resulted in decreased cell viability (Fig 8D).
To further examine the role ofMyh14 in cardiac remodeling in vivo, we obtainedMyh14-/-
mice from the Adelstein lab [40]. Wild-type, heterozygous (Myh14+/-) and homozygous
(Myh14-/-) littermates were not phenotypically different and no disproportionate spontaneous
sudden death was observed inMyh14 deficient mice (oldestMyh14-/- mouse 12 months to
Fig 7. Regional plots of LV hypertrophy at chromosome 7 across time points. A. Regional plot for LVM at baseline. B. Regional plots for ISO-
induced LVM hypertrophy at week 1. C. Regional plots for ISO-induced LVM hypertrophy at week 2. D. Regional plot for ISO-induced LV weight
hypertrophy at week 3.
doi:10.1371/journal.pgen.1006038.g007
AGenome-Wide Association Study of Heart Failure in Mice
PLOS Genetics | DOI:10.1371/journal.pgen.1006038 July 6, 2016 17 / 30
date). qPCR analysis showed a complete loss ofMyh14 expression inMyh14-/- hearts (Fig 9H).
ISO-induced LVM and LVIDd hypertrophy were significantly increased inMyh14-/- and
Myh14+/- versus wild-type controls (Fig 9A and 9B). There were no significant differences in
baseline EF among genotypes but ISO-treatedMyh14-/- mice demonstrated a trend towards EF
reduction compared toMyh14+/- and WT mice (Fig 9C). Cardiomyocyte cross-sectional area,
as measured by wheat germ agglutinin (WGA) staining, showed that cardiomyocytes from
ISO-treatedMyh14-/- mice were more significantly hypertrophied compared toMyh14+/- and
WTmice (Fig 9D and 9E). Histological sections ofMyh14-/- hearts revealed no abnormal phe-
notype at baseline but increased myocardial fibrosis and intercalated disc disarray after ISO
treatment (Fig 9F and 9G). RT-PCR demonstrated the up-regulation of immediate early gene
Fig 8. Myh14 knock-down in stressed neonatal rat ventricular myocytes (NRVMs) causes abrogation of hypertrophic
response and decreased cell viability. Knock-down ofMyh14 in NRVMs using siRNA (A), followed by ISO and phenylephrine
(PHE) treatments, showed theMyh14 knock-down treated NRVMs displayed poor attachment to tissue culture plates (B), did not
undergo characteristic hypertrophy (C) and resulted in decreased cell viability based on MTT assay (D). Error bars are SEM,
n = 3. * denotes p < 0.05.
doi:10.1371/journal.pgen.1006038.g008
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Myc, fetal gene Nppb, and fibrosis gene Lgals3 in ISO-treatedMyh14 deficient hearts compared
to controls (Fig 9H).
The HMDP resource
The study data, including gene-gene and gene-trait correlations as well as clinical trait and
transcript mapping, can be accessed via a user-friendly web-based interface at http://systems.
genetics.ucla.edu/.
Fig 9. Myh14 deficiency under ISO results in LVM hypertrophy, LVIDd dilation, increased cardiomyocyte size, fibrosis, intercalated disc
disarray, and hypertrophic signals. Female mice of wild-type (WT), heterozygous (HET) and knockout (KO)Myh14 genotypes were treated with
ISO at 10–12 weeks of age (n = 6, 9, and 7, respectively).Myh14 deficiency conferred an increase in ISO-induced LVM hypertrophy (A) and LVID
dilation (B). There was a trend towards decreased ISO-induced EF (C) due toMyh14 deficiency. Cardiomyocyte cross-sectional area, as measured by
wheat germ agglutinin (WGA) staining (D), showed that cardiomyocytes from ISO-treated KOmice were more significantly hypertrophied compared to
HET andWTmice (E). Dark gray bars (baseline in A and B; average of baseline and week 1 in C; control in E). Light gray bars (average of weeks 1–3
measures in A and B; average of weeks 2–3 measures in C; ISO-treated in E).Myh14 deficiency conferred an increase in ISO-induced fibrosis (blue
arrow) by Masson’s trichrome staining (F) and an increase in intercalated disc disarray (blue arrow) by β-catenin staining (G). Cardiac tissue gene
expression of hypertrophic and fibrosis markers were examined by RT-PCR at the end of a 3-week ISO infusion (H).Myc, Nppb, and Lgals3were
increased withMyh14 deficiency. Error bars are SEM, n = 3. * represents t-test p-value < 0.05. ** represents t-test p-value < 0.005.
doi:10.1371/journal.pgen.1006038.g009
AGenome-Wide Association Study of Heart Failure in Mice
PLOS Genetics | DOI:10.1371/journal.pgen.1006038 July 6, 2016 19 / 30
Discussion
Human HF GWAS have identified a handful of genetic determinants that explain a small pro-
portion of the genetic variance, in spite of involving tens of thousands of individuals [46].
Given the breadth of etiological and clinico-pathological heterogeneity, even larger cohorts
may not be big enough to discriminate signals from noise. We carried out an alternative
approach in the mouse, which has several advantages over human. First, we used multiple mice
per strain and were able to fully control the age, environment, severity and timing of cardiac
injury, to accurately assess cardiac remodeling with minimal confounding. As a result, our her-
itability estimates of LVM were significantly higher than that in human of 24–32% in the Fra-
mingham Heart Study [47] and 36–47% in an Australian twin study [48]. The relatively high
heritability provided sufficient power to uncover novel loci not previously identified in human.
Second, the HMDP strains have either been sequenced or densely genotyped, eliminating geno-
typing costs and errors. Third, access to control and ISO LV transcriptome as well as sequence
variation in 17 of the classical inbred strains available from the Wellcome Trust Mouse
Genomes Project (MGP) allowed us to examine cis-eQTL, transcript-to-trait correlations, and
functional variants to prioritize candidate genes and generate hypotheses for functional valida-
tion without prior knowledge in an unbiased manner, thus overcoming some of the challenges
of working with relatively long LD in mice. Given the paucity of association signals in humans,
we consider the association signals we observed in mice to be complementary to existing
human studies. While the individual genetic variants observed in mice may not be identical to
the variants observed in human populations, candidate genes from this study help identify
genes and/or pathways participating in modifying mechanisms of heart failure pathology.
We recognize that using only one gender is a limitation of our study that prevents us to
readily extrapolate our findings to male mice. During the pilot phase of the study, we observed
a slightly wider phenotypic separation among the 4 core classical inbred strains (A/J, C57BL/
6J, C3H/HeJ, and DBA/2J) in females than in males, which is important for our association
mapping study design. Under the constraints of cost for animal procurement and maintenance,
we chose to study females only. We believe that at least some of the findings observed in
females will likely recapitulate in males, since gender differences in mortality in humans appear
to be predominantly due to factors, such as age, co-morbidities and treatment approaches [49],
rather than gender itself. Moreover, higher rates of mortality and cardiogenic shock have been
observed in women compared with men after acute myocardial infarction [49], yet females are
under represented in both human and mouse studies.
Our study established an echocardiographic reference range for 100+ inbred mouse strains. To
minimize the variability to handling among different mouse strains, inhaled isoflurane, one of the
most commonly used agent for prolonged anesthesia inmice, was administered during echocardi-
ography. Based on recent studies on sedated mice, FS of 33% and 32% in 129X1/SvJ male and
C57BL/6J female mice were similar to our strain averages of 33% and 34%, respectively [50,51].
Inhaled anesthetics, including isoflurane, are known cardiac depressants, especially upon
deep sedation. In a study involving C57BL/6 male mice, mean arterial pressure (MAP), HR,
and body temperature at an isoflurane concentrations of 1.5% (volume-to-volume, v/v)
remained comparable to the conscious state for up to 90 minutes post-induction [52]. In
another study using C57BL/6 male mice, where HR was fixed at different dosages/depths of
isoflurane [53], echocardiographic measurements were found to be highly reproducible at a
high HR (475–525 bpm) but were correlated with HR under a low HR (350–400 bpm).
Although no comparable prior data exist for the vast majority of the mouse strains in our
study, we empirically observed that different mouse strains exhibited variable sensitivity to
anesthesia and that HR correlated to a number of echocardiographic measures representing
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cardiac inotropy and chamber size (S6B Fig). Therefore, we adjusted for HR as a covariate and
a surrogate for isoflurane sensitivity in our analysis. In spite of concerns regarding HR being a
confounding factor and surrogate marker for variable isoflurane sensitivity, correlations
among echocardiographic measures remained roughly unchanged, before and after adjusting
for HR, consistent with relatively minor cardiac depressive effects of isoflurane.
In spite of ongoing inotropic stimulation by ISO throughout the 3-week treatment time
course, some strains displayed the same or decreased FS at later ISO time points compared to
baseline, consistent with a decrease in contractile reserve—an observation in early HF stages of
decreased cardiac function augmentation to direct inotropic stimulation—marked by reduced
beta-adrenergic receptors along with altered sarcoplasmic reticulum Ca2+-adenosine triphos-
phatase 2a (SERCA2a) and phospholamban [54]. Our narrow-sense heritability estimates were
roughly half of broad-sense heritability estimates, suggesting that both additive and dominant/
epistatic genetic effects play important roles in the genetic variance of HF.
Our association analyses provided direct evidence that common genetic variation control
ISO-induced cardiac remodeling. The following considerations are relevant to the interpreta-
tion of the results. Equivalent dosages of ISO were given to each strain to control the degree of
cardiac insult. Although we could not control for ISO metabolism, we believe its contribution
to the results was minor. Linkage analysis using only the BXD RI strains resulted in a signifi-
cant reduction in resolution (S10 Fig). On the other hand, association analysis using only the
classical inbred strains suffered a significant loss of power (S11 Fig). Our study, which com-
bines the classical inbred and RI strains to achieve high genetic resolution and adequate statisti-
cal power, represents a substantial improvement over traditional linkage analysis. In addition,
panel-specific SNP selection based on minor allele frequency and missing genotype cutoffs
could indirectly affect association results. For example, SNPs that did not meet the minor allele
frequency and missing genotype cutoffs in the entire HMDP panel resulted in the loss of asso-
ciation signals around the 40 Mb region on chromosome 7 (S11C Fig). Moreover, genetic vari-
ation that is well represented among the BXD panel could contribute more substantially to the
association results, due to the fact that the BXD panel (44 strains) was highly represented
among the entire HMDP panel (104 strains) (S10 Fig). In the setting of a relatively narrow phe-
notypic spectrum, adjustments for uncorrelated covariates can deflate the association results.
For example, baseline FS, which was not correlated to BBW and has a similar narrow-sense
heritability estimate as ISO-treated FS, had two associated loci prior to but none after BBW
adjustment. Finally, the significantly associated loci explained about 23–38% of the total vari-
ance observed, which is significantly higher than in human HF GWAS.
In our previously published manuscript, we identified a number of heart weight and fibrosis
loci but none for ISO-induced LV weight hypertrophy [21]. A number of factors may have
hampered the detection of association signals for LV weight. For example, LV weight hypertro-
phy for each strain was estimated based on the difference of the strain averages from control
and ISO-treated cohorts. Given the small numbers of individuals in each cohort, variation in
LV weight due to variation in body size and cardiac chamber dissection may have introduced
errors in ISO-induced LV weight hypertrophy estimates per strain. In contrast, LVM was mea-
sured non-invasively, which allowed for repeated measurements in the same animal. The base-
line LVM estimate served as an internal control measure for body size in each mouse treated
with ISO. This approach represented an important advantage over our previous analysis,
which allowed us to estimate ISO-induced LVM hypertrophy more accurately and improve the
power of association analysis. Of note, the LVMmeasurements demonstrated a positive bias in
the upper ranges as a result of its derivation, which contains a constant multiplier:
LV mass ðPennÞ ¼ 1:04 ð½LVIDd þ PWd þ IVSd3  ½LVIDd3Þ  13; 6 g;
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where LVIDd represents left ventricular internal dimension at end diastole, PWd represents
posterior wall thickness at end diastole, and IVSd represents interventricular septal wall thick-
ness at end diastole.
In a mapping study, the spread rather than the absolute values of the data drives the associa-
tion analysis. Therefore, in spite of the positive bias in the upper ranges, LVM and LV weights
yielded similar association results (Figs 6C and 7D), with LV weight having a reduced statistical
significance as compared to LVM.
Our association analysis not only highlighted a number of genomic regions and genes for
HF susceptibility in mice, it also provides independent supportive evidence for syntenic regions
in humans and is complementary to existing and future human HF genome-wide association
and family-based linkage studies. For example, a candidate causal genomic region or gene for
HF or inherited cardiomyopathy in humans not reaching statistical significance may be recov-
ered based on additional supportive evidence from mice. Next, based on the central dogma
that the flow of genomic information starts from the DNA, to the RNA then to the phenotype
of interest, the cardiac transcriptome data allow us to generate hypotheses to test causal infer-
ence. For instance, when the transcript level of a gene in an association locus is associated with
genetic variation and correlates with phenotype, we may hypothesize that the gene could be
causally related to the phenotype, thereby facilitating prioritization of candidate genes in an
association locus (Fig 10). Our data could be used to explore the roles of individual candidate
genes in existing human GWAS loci. In addition, we have provided a rich data resource for the
HF research community to interrogate a given gene’s relationship with other genes in the car-
diac transcriptome. For example, a HF community researcher studying a novel HF gene X may
be interested in its upstream regulatory and downstream regulated genes. In addition to identi-
fying other genes in the cardiac transcriptome that correlated with gene X, a search for gene
X’s trans-eQTL, a distant locus controlling the expression of gene X, may reveal a number of
putative upstream regulators of gene X for hypothesis driven experiments and testing. On the
other hand, if gene X was regulated at the local level, identification of additional cardiac tran-
scripts regulated by the same locus could reveal gene X’s putative downstream targets. Finally,
the differentially expressed cardiac transcripts that correlated with cardiac remodeling pheno-
types represent a set of genes that may play important roles in HF pathogenesis and compensa-
tory changes and may be enriched for HF biomarkers. Our transcriptome data could
complement existing human transcriptome data, a valuable set of transcripts that represent the
true spectrum of human HF but whose RNA sample quality may be more variable, to identify
additional players of HF pathogenesis, compensatory changes and biomarkers.
Fig 10. Relationships between variation and correlated traits. There are three possible causal
relationships when there is correlation among a SNP (single nucleotide polymorphism) S, a transcript (RNA)
R, and a physiological or pathologic trait (phenotype) P. In the causal model, the SNP variation affects its
transcript levels leading to the resulting phenotype. In the reactive model, the SNP acts on the phenotypes,
which in turn affects transcript. In the independent model, the SNP variation acts on both the phenotype and
transcript independently.
doi:10.1371/journal.pgen.1006038.g010
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Our study implicated Klf4 andMyh14 to be negative regulators of cardiac hypertrophy
under ISO stress. Our results showed that the degree of LVM hypertrophy was inversely corre-
lated with the expression of Klf4 (S9 Fig). Since the expression of Klf4 expression was geneti-
cally determined by the cis-eQTL, our findings suggest that Klf4 expression may be causally
related to the degree of LVM hypertrophy. In other words, the higher the Klf4 expression, the
lesser the degree of LVM hypertrophy. We note, however, that our data does not provide proof
of a causal relationship, since a significant fraction of Klf4 expression occurs in trans, but is
consistent with findings from previous literature showing that KLF4 is a negative modulator of
ISO-induced LVM. Klf4, or Krüppel-like factor 4, a zinc-finger transcriptional regulator best
known as one of the four Yamanaka factors that are sufficient to reprogram differentiated cells
into embryonic-like induced-pluripotent stem cells (iPSCs) [55], has recently emerged as an
important modulator of cardiomyocyte hypertrophy. Cardiomyocyte-specific deletion of Klf4
in mice resulted in a slightly increased heart weight and increased ANF levels compared to con-
trols. When subjected to pressure overload, these mice developed increased pathologic cardiac
hypertrophy, fibrosis, apoptosis and mortality, compared to control banded mice [56]. In vitro
studies confirmed that KLF4 binds to the ANF and GATA4 promoters and acts as a repressor
of cardiomyocyte hypertrophy [57].
Myh14 was the only gene expressed in the heart that was located at the chromosome 7 locus
affecting cardiac hypertrophy in our study.Myh14, myosin heavy polypeptide 14, encodes the
heavy chain of the molecular motor nonmuscle myosin II-C (NMIIC), which is a member of
the nonmuscle myosin II motor protein family that plays an integral role in mechanotransduc-
tion, converging external and cell-generated forces by interacting with cytoskeletal actin. When
bred in a background of non-muscle myosin II-B (NMIIB) hypomorphic mice expressing only
12% of wild-type amounts of NMIIB protein,Myh14-/- mice developed marked cardiac myo-
cyte hypertrophy, interstitial fibrosis and diffuse N-cadherin and β-catenin patterns at the
intercalated discs, where NMIIB and NMIIC colocalized [40]. Collectively, these prior studies
implicated Klf4 andMyh14 as negative regulators of stress-induced cardiac hypertrophy in
vivo, which is also supported by our results.
In our in vivo study, we showed thatMyh14 deficient mice exhibited increased ISO-induced
LVID dilation, LVM hypertrophy, cardiac fibrosis, and hypertrophic markersMyc and Nppb.
On the other hand, In vitro siRNA knockdown ofMyh14 in NRVMs failed to elicit a hypertro-
phic response when stimulated with ISO but rather displayed poor attachment to the tissue cul-
ture plates and poor survival. As a non-muscle myosin,Myh14 is ubiquitously expressed and
could act through non-cardiomyocytes to modulate cardiomyocyte growth and hypertrophy.
We focused onMyh14 inside cardiomyocytes due to a previous study demonstrating the loca-
tion ofMyh14 in the intercalated disc and its implicated role at the cell-cell junction [40]. Since
NRVMs in tissue culture do not fully recapitulate the three-dimensional structure of the heart,
the consequence ofMyh14 deficiency may be quite different in vitro versus in vivo. These seem-
ingly discrepant results raise important questions regarding the mechanisms through which
Myh14 deficiency leads to cardiomyocyte death in the absence of mechanotransduction stress
in vitro and cardiac hypertrophy on an organ level in vivo.
To further explore mechanisms mediatingMyh14 deficiency in LVM hypertrophy, we que-
ried the existing HMDP cardiac transcriptome database available via http://systems.genetics.
ucla.edu/ [58]. We found that the cis-eQTL locus that controlsMyh14 expression also controls
Foxo1 in trans (p-value = 1.20x 10−5) and that the expression of Foxo1 was significantly posi-
tively correlated withMyh14 (bicor = 0.74, p-value = 6.7 x 10−18), which implicated Foxo1, a
forkhead family transcription factor, as a potential mediator ofMyh14. In addition,Myh14
expression was correlated with Cdk11b (bicor = 0.59, p-value 1.53 x 10−10) and Cdk11b was
controlled by theMyh14 locus (rs32804715, p-value = 9.08 x 10−6), which implicated Cdk11b, a
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member of the cyclin-dependent kinase family known to be a negative regulator of normal cell
cycle progression, as a potential mediator ofMyh14.
Moreover, we showed that ISO-treatedMyh14 deficient heart demonstrated disrupted
assembly of intercalated discs involving β-catenin, which is a dual function protein that pro-
vides cell-cell connections at the adherens junctions in the intercalated disc, to facilitate
mechanical and electrical coupling between adjacent cardiomyocytes, and regulates gene tran-
scription as a transcriptional coactivator, raising the possibility that disordered β-catenin local-
ization in the intercalated disk due toMyh14 deficiency could have direct consequences on β-
catenin signaling. In fact, altered intercalated disc architecture in cardiac muscle hypertrophy
and HF has previously been associated with altered β-catenin abundance [59], subcellular
localization [60], and canonical Wnt/β-catenin/TCF signaling. Interestingly, transcription fac-
tors FOXO and TCF are known to compete to interact with β-catenin [61]. Our experimental
results showed thatMyh14 is important in the maintenance of normal cardiac structure under
ISO stress and that the loss ofMyh14 exacerbates the hypertrophic response to ISO. Further
understanding of the crosstalk betweenMyh14, β-catenin, and Foxo1, will likely reveal impor-
tant mechanisms regarding howMyh14 deficiency leads to cardiac hypertrophy under ISO
stress.
Cardiac remodeling is one of the most important prognostic determinants of clinical HF.
Our study results provide an important resource to the HF research community and highlight
the strength of a systems approach to studying HF. The integration of high throughput molec-
ular phenotypes, such as genomic and transcriptomic data, provides a means to identify novel
candidate causal genes and a powerful alternative to human studies to understand the complex
interactions underpinning phenotypic variation of cardiac remodeling. Similar to human
GWAS, many of our lead SNPs lie in noncoding regions. Future directions will include
sequence-based computational approaches to systematically prioritize functional regulatory
variants. Future insights in how common genetic variations in a population modify HF pro-
gression will further shed light on genetic risk profiling, gene-gene and gene-environment
interactions as well as the design of personalized therapies for HF patients.
Supporting Information
S1 Fig. Baseline and week 3 echocardiographic measures in control mice. (A) Baseline and
week 3 echocardiographic measures in control mice were significantly correlated. (B) Bland-
Altman plots demonstrated agreement between baseline and week 3 echocardiographic mea-
sures in control mice. IVSd represents the interventricular septal wall thickness during diastole.
LVIDd represents the left ventricular internal dimension during diastole. LVM represents left
ventricular mass. FS represents fractional shortening. Each data point represents a mouse in
the control group.
(PDF)
S2 Fig. Association results from EMMA and FaST-LMM. The manhattan plots for the
change in week 1 IVSd show that association p-values by EMMA and FaST-LMM analyses
were similar.
(PDF)
S3 Fig. Left ventricular weight and echocardiographic estimates of left ventricular mass
were significantly and highly correlated. (A) LVM at baseline versus control LV. (B) LVM
versus LV after ISO for 3 weeks. (C) The change in LVM from baseline to week 3 of ISO versus
the difference in the strain-averaged LV weights between control and ISO. Bland-Altman plots
(bottom row) showing the agreement between LV and LVM are provided below. (D)
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Comparison of LV and LVM phenotypic spectra between control and isoproterenol hearts at
week 3.
Each data point represents a mouse strain.
(PDF)
S4 Fig. Variation in the echocardiographic measures of cardiac structure and function
among mouse strains. (A) Black bars represent measurements under the baseline condition.
White bars represent measurements after 3 weeks of continuous ISO infusion. Data presented
in alphabetical order of strain names. Error bars represent the standard errors of the means.
(B) Gray bars represent the differences in measurements between baseline and week 3 of con-
tinuous ISO infusion in ranked order.
(PDF)
S5 Fig. The spectrum of LVM among C57BL/6, DBA/2, and BXD recombinant inbred
strains. The baseline LVM and week 3 LVM for each of the C57BL/6, DBA/2, and BXD RI
strains (top). The change in LVM at week 3 for C57BL/6, DBA/2, and BXD RI strains (bottom).
Error bars represent the standard error of the means.
(PDF)
S6 Fig. Relationships between baseline body weight, heart rate and echocardiographic mea-
sures. (A) Relationships between echocardiographic measures and baseline body weight. BBW
represents baseline body weight. (B) Relationships between echocardiographic measures and
heart rate at corresponding time points. HR represents heart rate. (C) Relationships between
HR across time points. Each data point represents a mouse strain.
(PDF)
S7 Fig. Relative magnitude of heritability estimates. Line repeatability and marker-based h2
estimates for echo measures IVSd, LVIDd, LVM, and FS at baseline, week 1, week 2, and week
3 of ISO are compared.
(PDF)
S8 Fig. Fine mapping of LVM at chromosome 4 across time points. A. Regional plot for
LVM hypertrophy at week 1. B. Regional plot for LVM hypertrophy at week 2. C. Regional plot
for ISO-treated LV hypertrophy at week 3. D. Regional plot for the ISO-treated Klf4 expression
(ILMN_1221264) around SNP rs27794497 (purple).
(PDF)
S9 Fig. Correlation between Klf4 transcript levels and week 3 LVM. Color circles represent
SNP genotype at rs27811538. Bicor correlation and p-values are provided above. Pearson cor-
relation between LVM and Klf4 are as follows: Control ILMN_1241903 r = -0.28 p-
value = 0.01, ISO ILMN_1241903 r = -0.21 p-value = 0.07; Control ILMN_1221264 r = -0.23
p-value = 0.04, ISO ILMN_1221264 r = -0.21 and p-value = 0.07.
(PDF)
S10 Fig. Comparative analysis of classical inbred, BXD, and all HMDP strains. The
genome-wide and chromosome 9 manhattan plots for the change in week 1 IVSd analyzed
using the classical inbred strains only (A) and all of the HMDP strains (C). The genome-wide
and chromosome 9 linkage maps for the change in week 1 IVSd analyzed using the BXD
recombinant inbred strains only (B).
(PDF)
S11 Fig. Comparative analysis of classical inbred, BXD, and all HMDP strains. The
genome-wide and chromosome 7 manhattan plots for the change in week 3 LVM analyzed
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using the classical inbred strains only (A) and all of the HMDP strains (C). The genome-wide
and chromosome 7 linkage maps for the change in week 3 LVM analyzed using the BXD
recombinant inbred strains only (B).
(PDF)
S1 Table. The reproducibility of echocardiographic measures in control mice.
(PDF)
S2 Table. Differentially regulated genes by isoproterenol treatment. A. Significantly up- or
down-regulated cardiac genes by isoproterenol treatment. B. DAVID gene ontology analysis of
up-regulated cardiac genes. C. DAVID gene ontology analysis of down-regulated cardiac
genes. D. Summary of DAVID gene ontology analysis of cardiac genes correlated to echocar-
diographic measures. DAVID gene ontology analysis was performed based on top 1000 corre-
lated cardiac genes for each echocardiographic measures either at baseline or at wee 3 of
isoproterenol. Gene clusters exceeding nominal p-value 0.05 are shown.
(XLSX)
S3 Table. The number of births by gender and genotypes inMyh14+/- crosses.
(PDF)
S4 Table. Study sample characteristics of the HMDP across isoproterenol treatment time
points.
(PDF)
S5 Table. Echcardiographic measures of cardiac structure and function at different isopro-
terenol treatment time points by HMDPmouse strains.
(PDF)
S6 Table. Summary of association loci and loci gene differential expression, cis-eQTL, cor-
relation to trait and sequence variations. A. Summary of genetic loci by trait. Weight traits
such as total heart (TH), left ventricle (LV) and right ventricle (RV) weights are denoted by the
prefix wt. Echo traits are denoted by the prefix w1 for week 1, w2 for week 2, and w3 for week 3
followed by echo for measurement or delta for the difference compared to baseline at the corre-
sponding time point. Genomic coordinates were listed in mm9. B. Genes within the association
loci were queried using a custom computational pipeline to examine the presence of differential
expression with isoproterenol, cis-eQTL, correlation to trait of interest and sequence or struc-
tural variations.
(XLSX)
S7 Table. SNPs with association p-value< 0.001. Select SNPs from our analysis that exceed
the association p-value threshold of< 0.001.
(XLSX)
S8 Table. Human and mouse cardiovascular GWAS overlap genes.
(PDF)
S9 Table.Myh14 cis-eQTL across multiples tissues in different HMDP datasets.
(PDF)
S10 Table.Myh14 correlation to heart weight in different HMDP datasets.
(PDF)
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